Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04539821 · ClinicalTrials.gov registry record · NA

Virtual Pain Care Management (COVID-19)

A NA study of Chronic Pain, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
44
Enrollment target
2
Study locations

NCT04539821 is a NA study of Chronic Pain that has completed, run by VA Office of Research and Development. The registered enrollment target is 44 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04539821, a NA study of Chronic Pain, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
44 participants
Enrollment target
2
Study locations

Study Summary

The COVID-19 pandemic is exacerbating the challenges faced by Veterans at risk of opioid overdose including Veterans prescribed moderate-to-high dose long-term opioid therapy (LTOT) whose usual treatment resources and coping strategies may be inaccessible. This project combines established VA care components to deploy and evaluate virtual models of care for Veterans on high-risk LTOT to meet the dual challenges of maintaining social distancing and delivery high quality care.

Conditions Studied

Interventions

  • OTHER VCPM

Study Locations (2)

Colorado

  • Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora

Connecticut

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2020-10-01
Est. Completion 2021-08-12
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04539821

The ClinicalTrials.gov registry entry for NCT04539821 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (94% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which VCPM is the first listed.

NCT04539821 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Connecticut.

Frequently Asked Questions

What is clinical trial NCT04539821 about?

NCT04539821 is a clinical study titled "Virtual Pain Care Management (COVID-19)". The COVID-19 pandemic is exacerbating the challenges faced by Veterans at risk of opioid overdose including Veterans prescribed moderate-to-high dose long-term opioid therapy (LTOT) whose usual treatment resources and coping strategies may be inaccessible. This project combines established VA care c...

What is the current status of trial NCT04539821?

This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2020-10-01. Estimated completion is 2021-08-12.

What conditions does trial NCT04539821 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT04539821?

The interventions under investigation include: VCPM (OTHER).

Who is sponsoring clinical trial NCT04539821?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04539821 being conducted?

This trial has 2 study locations across Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.